| Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors G Mesiano, M Todorovic, L Gammaitoni, V Leuci, L Giraudo Diego, ... Expert opinion on biological therapy 12 (6), 673-684, 2012 | 249 | 2012 |
| Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features L Gammaitoni, L Giraudo, V Leuci, M Todorovic, G Mesiano, F Picciotto, ... Clinical Cancer Research, 2013 | 95 | 2013 |
| Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas D Sangiolo, G Mesiano, L Gammaitoni, V Leuci, M Todorovic, L Giraudo, ... Cancer research 74 (1), 119-129, 2014 | 86 | 2014 |
| CD44v6 as innovative sarcoma target for CAR-redirected CIK cells V Leuci, GM Casucci, G Grignani, R Rotolo, U Rossotti, E Vigna, ... Oncoimmunology 7 (5), e1423167, 2018 | 41 | 2018 |
| Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells L Gammaitoni, L Giraudo, M Macagno, V Leuci, G Mesiano, R Rotolo, ... Clinical Cancer Research 23 (9), 2277-2288, 2017 | 40 | 2017 |
| BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody M Sanlorenzo, I Vujic, A Floris, M Novelli, L Gammaitoni, L Giraudo, ... Clinical Cancer Research, clincanres. 1914.2017, 2018 | 35 | 2018 |
| Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers M Todorovic, G Mesiano, L Gammaitoni, V Leuci, LG Diego, ... Journal of Immunotherapy 35 (7), 579-586, 2012 | 31 | 2012 |
| Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity V Leuci, F Maione, R Rotolo, E Giraudo, F Sassi, G Migliardi, M Todorovic, ... Journal of translational medicine 14 (1), 119, 2016 | 28 | 2016 |
| Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy. G Mesiano, G Grignani, E Fiorino, V Leuci, R Rotolo, L D'Ambrosio, ... OncoImmunology, 1-29, 2018 | 25 | 2018 |
| Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective L Gammaitoni, V Leuci, G Mesiano, L Giraudo, M Todorovic, ... Expert opinion on biological therapy 14 (9), 1259-1270, 2014 | 25 | 2014 |
| Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors V Leuci, G Mesiano, L Gammaitoni, M Aglietta, D Sangiolo Current gene therapy 14 (1), 52-62, 2014 | 23 | 2014 |
| UNIVERSITA DEGLI STUDI DITORINO V Leuci, G Mesiano, L Gammaitoni, M Aglietta, D Sangiolo | 23* | |
| Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and … V Leuci, G Mesiano, L Gammaitoni, C Cammarata, S Capellero, ... Journal of biotechnology 156 (3), 218-226, 2011 | 19 | 2011 |
| Adoptive immunotherapy against sarcomas G Mesiano, V Leuci, L Giraudo, L Gammaitoni, F Carnevale Schianca, ... Expert opinion on biological therapy 15 (4), 517-528, 2015 | 16 | 2015 |
| Efficient Transcriptional Targeting of Human Hematopoietic Stem Cells and Blood Cell Lineages by Lentiviral Vectors Containing the Regulatory Element of the Wiskott‐Aldrich … V Leuci, L Gammaitoni, S Capellero, D Sangiolo, M Mesuraca, HM Bond, ... Stem Cells 27 (11), 2815-2823, 2009 | 14 | 2009 |
| Sustained Long‐Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third‐Generation Lentiviral Vectors M Tesio, L Gammaitoni, M Gunetti, V Leuci, Y Pignochino, N Jordaney, ... Stem Cells 26 (6), 1620-1627, 2008 | 12 | 2008 |
| Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy V Leuci, G Mesiano, L Gammaitoni, M Todorovic, L Giraudo, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2014 | 8 | 2014 |
| Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells L Gammaitoni, L Giraudo, V Leuci, G Mesiano, M Cangemi, A Zaccagna, ... Journal of translational medicine 13 (1), O1, 2015 | 4 | 2015 |
| effective preclinical adoptive immunotherapy with cytokine-induced killer cells for bone sarcomas: o435 D Sangiolo, G Mesiano, C Cammarata, M Todorovic, L Caione, V Leuci, ... Bone Marrow Transplantation 46, S87, 2011 | 4 | 2011 |
| Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks D Sangiolo, V Leuci, S Gallo, M Aglietta, W Piacibello Expert opinion on biological therapy 11 (5), 655-666, 2011 | 3 | 2011 |
